All In MedTech

Device Trial Radar · NCT00805948

Post-Approval Clinical Study of the Talent Thoracic Stent Graft to Treat Thoracic Aortic Aneurysms (THRIVE)

Descending Thoracic Aortic Aneurysm Endovascular Repair Post-approval Study (THRIVE)

Last checked: Nov 20, 2026Latest source record: Sep 27, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

349

Actual

Start

Apr 2009

Primary completion

Aug 2016

Study completion Aug 2017

Sponsor

Lead sponsor
Medtronic CardiovascularPublic (MDT)
Sponsor type
Industry
Collaborators
Medtronic
First posted
Dec 10, 2008

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the long-term safety and effectiveness of the Talent Thoracic Stent Graft System for treatment of descending thoracic aneurysms (DTA)following U.S. market approval.

Conditions

  • Thoracic Aortic Aneurysms

Interventions

  • Talent Thoracic Stent Graft SystemDevice

    endovascular repair of descending thoracic aortic aneurysms using the Talent Thoracic Stent Graft System.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Freedom From Aneurysm-related Mortality at 5 YearsTime frame: 5 years

Locations

26 sites in 1 country. Site status is shown where the registry gives one.

  • Cedars Sinai Medical Center

    Los Angeles, California

  • Harbor-UCLA

    Torrance, California

  • Washington Hospital D.C.

    Washington D.C., District of Columbia

23 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.